VENUS REMEDIES Announces Quarterly Results (3QFY19); Net Profit Down 2301.8%
Fri, 22 Feb

VENUS REMEDIES has announced its results for the quarter ended December 2018. Here is a detailed performance review of the same:

VENUS REMEDIES Quarterly Financials

No. of Mths
Qtr. Ending
3
Dec-17*
3
Sep-18*
3
Dec-18*
QoQ ChangeYoY Change
Net SalesRs m931809691-14.6%-25.8%
Other incomeRs m1125-60.6%240.1%
TurnoverRs m933821695-15.3%-25.5%
ExpensesRs m754644643-0.1%-14.7%
Gross profitRs m17716547-71.3%-73.2%
DepreciationRs m8983830.0%-7.1%
InterestRs m8491943.4%12.1%
Profit before taxRs m53-125-4194.8%-2404.2%
TaxRs m0-5-60.0%
Profit after taxRs m58-119-1595.5%-2301.8%
Gross profit margin%19.020.46.9
Effective tax rate%0.0-161.64.4
Net profit margin%0.61.0-17.2
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter fell 25.8% on a year-on-year (YoY) basis. The expenses were down by 14.7% YoY during the same period.
  • The company's operating profit declined by 73.2% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 6.9% in 3QFY19 as against 19.0% in 3QFY18.
  • Depreciation charges declined by 7.1% and finance costs increased by 12.1% YoY, respectively.
  • Other income increased by 240.1% YoY during the quarter.
  • Net profit for the quarter declined by 2301.8% YoY. Net profit margins during the quarter declined from 0.6% in 3QFY18 to -17.2% in 3QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 14.6% on a quarter-on-quarter (QoQ) basis. The expenses were down by 0.1% QoQ during the same period.
  • The company's operating profit declined by 71.3% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 6.9% in 3QFY19 as against 20.4% in 2QFY18.
  • Net profit for the quarter declined by 1595.5% QoQ, while net profit margins declined from 1.0% in 2QFY18 to -17.2% in 3QFY19.

To see how VENUS REMEDIES has performed over the last eight quarters, please visit here.

VENUS REMEDIES Share Price Performance

Over the last one year, VENUS REMEDIES share price has moved up from Rs 77.7 to Rs 31.0, registering a Loss of Rs 46.7 or around 60.1%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,571.8 (up 0.5%). Over the last one year it has moved down from 13,958.5 to 13,571.8, a gain of 387 points (down 2.8%).

Overall, the S&P BSE SENSEX is up 6.0% over the year.

Current Valuations

At the current price of Rs 31.0, the price to book value (P/BV) ratio of VENUS REMEDIES stands at 0.1 times.